Read more about this disease, some with Classification – Types – Signs and symptoms – Genetics – Pathophysiology – Diagnosis – Screening – Prevention – Treatment and management – Cures and much more, some including pictures and video when available.
5-alpha-reductase deficiency (5-ARD) is an autosomal recessive intersex condition caused by a mutation of the 5-alpha reductase type 2 gene.[1]
5-alpha-reductase is an enzyme that converts testosterone to dihydrotestosterone (DHT) in peripheral tissues. 5-alpha-reductase deficiency-2 is biochemically characterized by low to low normal levels of testosterone and decreased levels of 5a-DHT, creating a higher testosterone/DHT ratio.
DHT is a potent androgen, necessary for the development of male external genitalia in utero.
The condition affects only males (i.e. those with a Y chromosome) because DHT has no known role in female development.[2]
Individuals with 5-ARD can have normal male external genitalia, ambiguous genitalia, or normal female genitalia. They are born with male gonads, including testicles and Wolffian structures, but usually appear to have female primary sex characteristics. Consequently they are often raised as girls and may develop a female gender identity. Individuals with obvious undervirilisation at birth, e.g. hypospadias, micropenis, or complete ambiguous genitalia, are currently raised as boys.
Individuals with 5-ARD are generally capable of producing viable sperm. In individuals with feminised or ambiguous genitalia, there is a tendency towards a macroclitoris or microphallus, and the urethra may attach to the phallus. This structure may be capable of ejaculations as well as erections, however artificial insemination techniques or in-vitro fertilisation are necessary, due to one’s inability to engage in intercourse.
At puberty, individuals often have primary amenorrhoea, and may experience virilisation. This may include descending of the testes, hirsutism (facial/body hair considered normal in males –not to be confused with hypertrichosis), and deepening of the voice. In adulthood, individuals do not experience male-pattern baldness.[1] As DHT is a far more potent androgen than testosterone alone, virilisation in those lacking DHT may be absent or reduced compared to males with functional 5-alpha reductase. It is hypothesized that rising testosterone levels at the start of puberty (around age twelve) are able to generate sufficient levels of DHT by either the action of 5-alpha-reductase type 1 (active in the adult liver, non-genital skin and some brain areas) or through the expression of low levels of 5-alpha-reductase type 2 in the testes.
[tubepress mode=’tag’, tagValue=’5-alpha-reductase deficiency’]